Predicting the state’s high court would adopt the innovator liability theory, a Connecticut federal judge denied GlaxoSmithKline’s motion to dismiss a product liability suit alleging that a generic drug manufactured and sold by another company led to the death of a Cornell University student from Westport in 2018.

Alan Doran, on behalf of his daughter, Rachel Hope Doran, filed a lawsuit in U.S. District Court for the District of Connecticut against GlaxoSmithKline PLC and GlaxoSmithKline LLC (GSK) under the Connecticut Product Liability Act, alleging claims for design defect, failure to warn, and misleading advertising.